MicroVision, Inc.
NASDAQ:MVISHardware, Equipment & Parts
-$0.00 today
- Market cap
- $52.19M
- Beta
- 1.16
- P/E (TTM)
- -1.2
- EPS (TTM)
- -$0.30
Volume 13.52M
Average 6.37M
MVIS Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
MicroVision, Inc.NASDAQ: MVIS
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development growth accelerates
Q1 FY2026 research & development of $14.45M rose 95.1% year over year, ahead of the -0.9% change in trailing-twelve-month research & development. Sequentially, it rose 66.4% from the prior quarter. Over 3 fiscal years it compounded at +1.4% a year.
Context
- Research & development amounted to 2625.8% of revenue in FY2025, up 1582.1 pp from a year earlier.
- Research & development increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +95.1% holds above the trailing-twelve-month pace of -0.9%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 31.72M USD
- Year-over-year change
- -35.3%
- 4-year CAGR
- +7.1%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 31.72M | -35.3% |
| FY2024 | 2024-12-31 | 49.02M | -13.6% |
| FY2023 | 2023-12-31 | 56.71M | +86.5% |
| FY2022 | 2022-12-31 | 30.41M | +26.1% |
| FY2021 | 2021-12-31 | 24.11M | — |
Research & Development vs competitors
How MVIS compares with its peers on the latest reported figures
- MVIS's LTM Mar 2026 research & development of $38.76M is the 3rd highest of the 11 companies compared; the peer median is $14.02M.
- Its year-over-year change of -0.9% is the 5th highest of 10, against a peer median of -12.7%.
- Research & development amounts to 2494.3% of revenue for MVIS, versus a peer median of 11.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $54.66M | -33.9% | -9.3% | 14.1% | |
| LTM Jan 2026 | $41.8M | -14.9% | — | 4.3% | |
| LTM Mar 2026 | $38.76M | -0.9% | +1.4% | 2494.3% | |
| LTM Mar 2026 | $28.96M | +16.8% | — | 71.8% | |
| LTM Mar 2026 | $21.26M | -12.7% | -21.9% | 23.6% | |
| LTM Mar 2026 | $14.11M | -20.5% | -7.8% | 28.5% | |
| LTM Mar 2026 | $13.93M | +33.8% | -27.7% | 197.0% | |
| LTM Jan 2026 | $5.64M | +0.4% | +6.9% | 8.3% | |
| LTM Mar 2026 | $3.72M | +44.2% | +13.7% | 5.9% | |
| LTM Mar 2026 | $0 | -100.0% | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding MVIS) | $14.02M | -12.7% | -8.5% | 11.2% | |
Competitors are the stored peer set for MVIS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2.5M | 664K | 7.26M | 4.7M | 1.21M |
| Cost of Revenue | 2K | 100K | 2.77M | 7.53M | 18.55M |
| Gross Profit | 2.5M | 564K | 4.49M | (2.83M) | (17.34M) |
| Gross Margin | 99.9% | 84.9% | 61.8% | -60.3% | -1435.4% |
| Research & Development | 24.11M | 30.41M | 56.71M | 49.02M | 31.72M |
| Selling, General & Admin | 0 | 0 | 0 | 0 | 20.33M |
| Operating Expenses | 46.37M | 54.45M | 93.36M | 82.69M | 52.05M |
| Depreciation & Amortization | 951K | 745K | 5.24M | 4.22M | 5.82M |
| EBITDA | (42.25M) | (52.28M) | (83.07M) | (70.98M) | (70.71M) |
| EBITDA Margin | -1690.0% | -7874.1% | -1144.4% | -1511.4% | -5853.5% |
| Operating Income | (43.87M) | (53.89M) | (88.88M) | (85.52M) | (69.39M) |
| Operating Margin | -1754.8% | -8116.0% | -1224.3% | -1821.1% | -5743.8% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 62K | 80K | 4.46M | 18.53M |
| Other Income / Expenses | 669K | 799K | 7.18M | (10.89M) | (25.68M) |
| Income Before Tax | (43.2M) | (53.09M) | (81.7M) | (96.41M) | (95.07M) |
| Pre-Tax Margin | -1728.0% | -7995.6% | -1125.4% | -2053.0% | -7869.6% |
| Income Tax Expense | 0 | 0 | 1.15M | 507K | (84K) |
| Net Income | (43.2M) | (53.09M) | (82.84M) | (96.92M) | (94.98M) |
| Net Margin | -1728.0% | -7995.6% | -1141.2% | -2063.8% | -7862.7% |
| EPS (Basic) | (0.27) | (0.32) | (0.45) | (0.46) | (0.35) |
| EPS (Diluted) | (0.27) | (0.32) | (0.45) | (0.46) | (0.35) |
| Weighted Avg Shares | 160.66M | 165.96M | 182.8M | 209.51M | 273.14M |
| Weighted Avg Shares (Diluted) | 160.66M | 165.96M | 182.8M | 209.51M | 273.14M |
MicroVision, Inc.
NASDAQ:MVIS
Intrinsic Alpha fair value
Locked
Current Price
$2.24
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.